Artesunate Amivas

Artesunate Amivas is an intravenous medication used for severe malaria treatment. This antimalarial drug is manufactured by Amivas Ireland Limited and is sourced from the EU.

Artesunate Amivas is primarily used for the treatment of severe malaria caused by Plasmodium falciparum. This medication is administered intravenously and is intended for use in hospital settings under medical supervision. Artesunate is often considered when other treatments are not suitable or effective.

Common effects of Artesunate Amivas may include fever reduction and improvement in malaria symptoms. As with any medication, individual responses can vary, and some patients may experience different effects.

Artesunate Amivas should be used with caution in patients with known allergies to artesunate or any of its components. It is important to follow medical advice and guidelines when administering this medication. Proper storage and handling are essential to maintain its effectiveness.

Artesunate Amivas may interact with other medications, including certain antimalarials and drugs that affect liver enzymes. It is important to inform healthcare providers about all medications being taken to avoid potential interactions.